retatrutide clinical trial results 2024 2025 retatrutide weight loss study Peptide Series #3 — 🧬🏃🏻‍♀️ BOOM🔥! The most POWERFUL DRUG EVER tested in a isn't approved yet. But the data is already rewriting what we thought was Michael Weintraub, MD on X:

The GIP receptor activation facilitates additional insulin secretion in a glucose-dependent manner and plays a critical role in lipid metabolism , contributing to reductions in fat deposition and improvements in overall energy balance

Small Group Sales Resource Center Important notes about the resource center: The resource center will replace the marketing landing pages

10.1111/bcpt.70021 Basic Clin Pharmacol Toxicol

GLP-1 agonists In the late 1980s a group of scientists identified the first GLP-1 agonist (Exendin-4) in animals

Abstract Background: Chronic kidney disease (CKD) affects 10% of the global population and leads to end-stage renal disease (ESRD)